Title: 5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks.
Journal: Cephalalgia : an international journal of headache20101001
Title: Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
Journal: Cephalalgia : an international journal of headache20101001
Title: Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.
Journal: Cephalalgia : an international journal of headache20101001
Title: 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics20100401
Title: Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Journal: Journal of medicinal chemistry20080626
Title: [3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
Journal: Naunyn-Schmiedeberg's archives of pharmacology20050301
Title: [3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain.
Journal: Naunyn-Schmiedeberg's archives of pharmacology20050301
Title: Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
Journal: Bioorganic & medicinal chemistry letters20041220
Title: Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT 1F receptor agonists.
Journal: Bioorganic & medicinal chemistry letters20040105
Title: Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
Journal: Journal of medicinal chemistry20030703
Title: Crystal forms of LY334370 HCl: isolation, solid-state characterization, and physicochemical properties.
Journal: Journal of pharmaceutical sciences20030601
Title: Treatment of acute migraine.
Journal: Lancet (London, England)20020302
Title: Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial.
Journal: Lancet (London, England)20011013
Title: The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Journal: British journal of pharmacology20010801
Title: Shepheard S, et al. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia. 1999 Dec;19(10):851-8.
